Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Malwina Barańska"'
Autor:
Małgorzata Nartowicz, Aleksandra Jaworska-Czerwińska, Małgorzata Chudzińska, Beata Pilarska, Ariel Liebert, Malwina Barańska, Kamila Tymosiak, Elżbieta Bernaciak, Walery Zukow
Publikováno v:
Journal of Education, Health and Sport, Vol 8, Iss 12, Pp 785-792 (2018)
Protocol ERAS - "Enhanced Recovery after Surgery" - is a modern multidisciplinary formula of perioperative care to improve treatment outcomes. Over the past few years, many attempts have been made to implement recommendations for the management of pa
Externí odkaz:
https://doaj.org/article/94af1f8cbf8a409abfa34ea6c1ac18e0
Autor:
Piotr Adamski, Malwina Barańska, Małgorzata Ostrowska, Wiktor Kuliczkowski, Katarzyna Buszko, Katarzyna Kościelska-Kasprzak, Bożena Karolko, Andrzej Mysiak, Jacek Kubica
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 4, p 1124 (2022)
Background: Contemporary antiplatelet treatment in acute myocardial infarction (AMI) is based on one of two P2Y12 receptor inhibitors, prasugrel or ticagrelor. The aim of this study was to compare diurnal variability of platelet reactivity between pa
Externí odkaz:
https://doaj.org/article/00247d1694db4d9781925fc55f45907d
Autor:
Tomasz Topoliński, Krzysztof Pstrągowski, Aldona Kubica, Robert Gajda, Łukasz Pietrzykowski, Ewa Zabielska, Tamara Sukiennik, Małgorzata Jasiewicz, Marzena Wawrzyniak, Malwina Barańska, Julia Maria Umińska, Lidia Manelska, Ewa Obońska, Michał Siedlaczek, Piotr Michalski, Ewa Laskowska, Klaudyna Grzelakowska, Jacek Kryś, Piotr Adamski, Piotr Niezgoda, Małgorzata Ostrowska, Eliano Pio Navarese
Publikováno v:
Medical Research Journal.
Autor:
Przemysław Sobczak, Bernd Jilma, Malwina Barańska, Piotr Niezgoda, Michał Piotr Marszałł, Katarzyna Buszko, Eliano Pio Navarese, Joanna Sikora, Adam Sikora, Jacek Kubica
Publikováno v:
Cardiology Journal. 29:432-440
Background: Numerous worldwide clinical trials have proven the indisputably negative influence of morphine on the pharmacokinetics and pharmacodynamics of P2Y 12 receptor inhibitors in patients presenting with acute coronary syndromes. The aim of thi
Autor:
Jacek Gessek, Mariusz Gąsior, Dariusz Wojciechowski, Diana A. Gorog, Jolanta Maria Siller-Matula, Jolita Badarienė, Robert J. Gil, Piotr Niezgoda, Agnieszka Tycińska, Małgorzata Ostrowska, Grzegorz Piotrowski, Jacek Legutko, Giuseppe Specchia, Julia M. Umińska, Wojciech Wojakowski, Łukasz Pietrzykowski, Jarosław D. Kasprzak, Bartosz Krakowiak, Andrzej Budaj, Marcin Nosal, Piotr Adamski, Miłosz Jaguszewski, Jarosław Gorący, Jarosław Wójcik, Marianna Janion, Maciej Lesiak, Sławomir Dobrzycki, Grzegorz Sobieszek, Andrzej Przybylski, Wacław Kochman, Marek Gierlotka, Łukasz Fidor, Aldona Kubica, Paweł Grzelakowski, Andrzej Kleinrok, Artur Klecha, Aleksander Żurakowski, Przemysław Podhajski, Adam Kern, Jacek Kubica, Tomasz Roleder, Marzenna Zielińska, Malwina Barańska, Stanisław Bartuś, Grzegorz Skonieczny, Tomasz Hajdukiewicz, Eliano Pio Navarese
Publikováno v:
Cardiol J
Cardiology journal, Gdańsk : Via Medica, 2021, vol. 28, iss. 4, p. 607-614
Cardiology journal, Gdańsk : Via Medica, 2021, vol. 28, iss. 4, p. 607-614
The risk of ischemic events gradually decreases after acute coronary syndrome (ACS), reaching a stable level after 1 month, while the risk of bleeding remains steady during the whole period of dual antiplatelet treatment (DAPT). Several de-escalation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8379519a84602c85a527b6ef2cfa8b01
https://europepmc.org/articles/PMC8277001/
https://europepmc.org/articles/PMC8277001/
Autor:
Jacek Kubica, Tomasz Fabiszak, Piotr Adamski, Joanna Sikora, Malwina Barańska, Katarzyna Buszko, Piotr Niezgoda, Eliano Pio Navarese, Aleksandra Karczmarska-Wódzka, Małgorzata Ostrowska
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Scientific Reports
High platelet reactivity (HPR) is a risk factor for stent thrombosis, a potentially lethal complication of percutaneous coronary intervention. HPR is also associated with increased risk of myocardial infarction and death in invasively-treated patient
Autor:
Dimitrios Alexopoulos, Eliano Pio Navarese, Adam Sikora, Jacek Kubica, Malwina Barańska, Piotr Adamski, Przemysław Sobczak, Wiktor Kuliczkowski, Tomasz Fabiszak, Joanna Sikora, Bernd Jilma, Katarzyna Buszko, Aldona Kubica, Michał Piotr Marszałł
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 5:139-148
Aims Currently available data indicate that reduction of ticagrelor maintenance dose (MD) 1-3 years after acute myocardial infarction (AMI) not only provides sufficient platelet inhibition but also can improve ticagrelor's safety profile. The aim of
Autor:
Wiktor Dariusz Sroka, Malwina Barańska, Krzysztof Pstrągowski, Piotr Niezgoda, Jolanta M. Siller-Matula, Jilma Bernd, Natalia Skibińska, Jacek Kubica, Eliano Pio Navarese, Joanna Sikora, Katarzyna Buszko, Diana A. Gorog, Michał Piotr Marszałł
Publikováno v:
Thrombosis and Haemostasis. 118:2126-2133
Extensive search for methods of overcoming morphine-related delay of the absorption and onset of action of oral P2Y12 inhibitors in patients presenting with acute coronary syndrome is on-going. The aim of the trial was to investigate whether metoclop
Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina
Autor:
Dimitrios Alexopoulos, Jolanta M. Siller-Matula, Piotr Niezgoda, Tomasz Fabiszak, Emilia Siemińska, Katarzyna Buszko, Adam Sikora, Joanna Sikora, Jacek Kubica, Bernd Jilma, Malwina Barańska, Michał Piotr Marszałł
Publikováno v:
Thrombosis and Haemostasis. 117:718-726
SummaryOral administration of crushed ticagrelor tablets turned out to be an efficacious method that improves its pharmacokinetics and pharmacodynamics. This strategy, however, is unlikely to eliminate the drug-drug interaction in patients receiving
Autor:
Piotr Niezgoda, Michał Piotr Marszałł, Grzegorz Grześk, Jacek Kubica, Malwina Barańska, Joanna Sikora, Emilia Siemińska, Krzysztof Pstrągowski, Aleksandra Karczmarska-Wódzka
Publikováno v:
Medical Research Journal. 1:68-71
Introduction. Nowadays, due to the “morphine effect”, the screening of methods that provide quick and effective platelet inhibition with oral P2Y12 inhibitors administrated simultaneously with morphine in patients with acute coronary syndromes ar